Related Experiment Video
Updated: Oct 9, 2025

Bioinformatics Resources for the Study of Glycan-Mediated Protein Interactions
Published on: January 20, 2022
Chemokines modulate glycan binding and the immunoregulatory activity of galectins
Lucía Sanjurjo1, Iris A Schulkens1, Pauline Touarin2
1Amsterdam UMC location VUmc, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Insights
Chemokines, such as CXCL4, can modulate the immune functions of galectins by altering their glycan-binding properties. This interaction specifically impacts T cell apoptosis, revealing a novel immunomodulatory pathway.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Galectins are key regulators of immune responses through glycan binding.
- Cytokines and chemokines are known to be modulated by galectins.
- The precise mechanisms of galectin-chemokine interactions in immunity require further elucidation.
Purpose of the Study:
- To investigate the inverse mechanism where chemokines control galectin immunomodulatory functions.
- To identify specific galectin-chemokine binding pairs and their functional consequences.
- To elucidate how chemokine binding affects galectin glycan-binding activity and specificity.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy to analyze protein-protein interactions.
- Assessment of galectin glycan-binding affinity and specificity.
- Functional assays measuring T cell apoptosis induced by galectin-chemokine complexes.
Main Results:
- Specific galectin-chemokine binding pairs were identified, including galectin-1/CXCL4 and galectin-9/CCL5.
- CXCL4 binding induced structural changes in galectin-1's carbohydrate-binding site, altering its glycan-binding properties.
- Galectin-1/CXCL4 enhanced apoptosis in CD8+ T cells, while galectin-9/CCL5 reduced apoptosis in CD4+ T cells.
Conclusions:
- Chemokines can directly control the immunomodulatory functions of galectins through specific binding.
- Galectin-chemokine interactions represent a novel mechanism for regulating immune cell responses, particularly T cell apoptosis.
- These findings offer new insights into the complex interplay between galectins and chemokines in immune regulation.
Abstract:
Galectins are versatile glycan-binding proteins involved in immunomodulation. Evidence suggests that galectins can control the immunoregulatory function of cytokines and chemokines through direct binding. Here, we report on an inverse mechanism in which chemokines control the immunomodulatory functions of galectins. We show the existence of several specific galectin-chemokine binding pairs, including galectin-1/CXCL4. NMR analyses show that CXCL4 binding induces changes in the galectin-1 carbohydrate binding site. Consequently, CXCL4 alters the glycan-binding affinity and specificity of galectin-1. Regarding immunomodulation, CXCL4 significantly increases the apoptotic activity of galectin-1 on activated CD8+ T cells, while no effect is observed in CD4+ T cells. The opposite is found for another galectin-chemokine pair, i.e., galectin-9/CCL5. This heterodimer significantly reduces the galectin-9 induced apoptosis of CD4+ T cells and not of CD8+ T cells. Collectively, the current study describes an immunomodulatory mechanism in which specific galectin-chemokine interactions control the glycan-binding activity and immunoregulatory function of galectins.
Related Concept Videos
Proteoglycans
Glycocalyx and its Functions
Protein Glycosylation
Glycosylation occurs in...
Selectins
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
GPCRs Regulate Adenylyl Cylase Activity

